Clinical Study
Mycobacterial Etiology of Pulmonary Tuberculosis and Association with HIV Infection and Multidrug Resistance in Northern Nigeria
Table 3
Unadjusted analysis comparing cases with resistance to isoniazid alone, rifampicin alone, both (MDR-TB), and those with any resistance to those without any drug resistance among participants receiving care at two TB treatment sites in northern Nigeria.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MDR-TB: multidrug resistant tuberculosis (resistance to both isoniazid and rifampicin). ANY resistance: Resistance to isoniazid, rifampicin, or both; NO resistance: not resistant to either isoniazid or rifampicin. *Odds ratio estimation not possible due to zero frequency cells. |